Celera Diagnostics, Merck Form Research Collaboration | GenomeWeb

NEW YORK, Oct. 20 (GenomeWeb News) - Celera Diagnostics said today that it has formed a research collaboration with Rosetta Inpharmatics, and its parent company Merck, to identify and validate genetic markers that can be used to develop tests and treatments for select cancers.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.